IDEXX Laboratories Inc
Gesloten
SectorGezondheidszorg
508.35 1.06
Overzicht
Wijziging aandelenprijs
24u
Min
500.03
Max
505.26
Inkomsten | 60M 338M |
|---|---|
Verkoop | 76M 1.2B |
K/W Sectorgemiddelde | 37.597 56.597 |
EPS | 4.27 |
Winstmarge | 27.817 |
Werknemers | 11,000 |
EBITDA | 68M 468M |
Volgende Winsten | 2 nov 2026 |
|---|
Marktkapitalisatie | -2.6B 42B |
|---|---|
Vorige openingsprijs | 507.29 |
Vorige sluitingsprijs | 508.35 |
Nieuwssentiment
By Acuity
41%
59%
98 / 339 Rangschikking in Healthcare
IDEXX Laboratories Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
IDEXX Laboratories Inc Prognose
Sentiment
By Acuity
98 / 339 Rangschikking in Gezondheidszorg
Nieuwssentiment
Bullish Bewijs
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Onder gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.